The main HistologiX Lab will reopen from 18th May following a detailed risk assessment.
Select a resource from the topic displayed
Gain deeper insights into your COVID-19 research with our integrated package from Tissue Solutions and HistologiX. Read more.
We would like to update our customers amid the ever-changing COVID-19 virus outbreak. To play our part in stopping the virus in its tracks, we have decided to temporarily close the main HistologiX Ltd. Lab from 25th March until further notice in line with the UK...
We would like to reassure you that it is business as usual and provide an update regarding our response to the outbreak of the COVID-19 virus as well as our commitment to serving you and your critically important work moving forward. Here are the measures that the...
Our Mission Statement
Meet our team at the 7th Immunotherapy of Cancer Conference (ITOC) in Munich, Germany. Learn about the advances and challenges of translational research in the field of immuno-oncology.
HISTOLOGIX CELEBRATES COMMITMENT TO REAL LIVING WAGE
HistologiX will hold a presence at the DPC this year. We would love to talk you through our slide scanning and archiving services via the Hamamatsu and Zeiss Digital Slide Scanners. We also use HALO™ Image Analysis on behalf of our clients and provide scientific interpretation to aid your study decisions.
If you are planning to attend this popular event, please visit us at Booth #15 to learn about our advances in all of the above therapeutic areas.
Visit stand #2 at Next Gen Immuno-Oncology Congress, on. 19-20th September 2019 to meet our team and discuss how we might be able to drive your immuno-oncology programmes